SAREPTA THERAPEUTICS, INC. Loans Payable
SAREPTA THERAPEUTICS, INC. (SRPT) had Loans Payable of $29.08 million as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Loans Payable
us-gaap:LoansPayable · last filed 2018-03-01
- 2017-12-31: Loans Payable $29.08M.
- 2017-09-30: Loans Payable $31.28M.
- 2016-12-31: Loans Payable $14.78M; Loans Payable as first filed $16.15M.
| Period end | Loans Payable | Loans Payable as first filed |
|---|---|---|
| 2017-12-31 | $29.08M 10-K · filed 2018-03-01 | |
| 2017-09-30 | $31.28M 10-Q · filed 2017-11-01 | |
| 2016-12-31 | $14.78M 10-K · filed 2018-03-01 | $16.15M 10-Q · filed 2017-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |